-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Cadrenal Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q1 2022 to Q3 2025.
- Cadrenal Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -1.31 USD/shares, a 39.9% increase year-over-year.
- Cadrenal Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was -8 USD/shares, a 41.4% increase year-over-year.
- Cadrenal Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -8.73 USD/shares, a 6.03% increase from 2023.
- Cadrenal Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -9.29 USD/shares, a 993% decline from 2022.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)